Laboratorio Reig Jofre, S.A. (BME:RJF)

Spain · Delayed Price · Currency is EUR

2.800

+0.050 (1.82%)

At close: Dec 5, 2025

3.32% (1Y)

Market Cap	227.89M
Revenue (ttm)	330.34M
Net Income (ttm)	4.25M
Shares Out	81.39M
EPS (ttm)	0.05
PE Ratio	53.62
Forward PE	15.56
Dividend	0.05 (1.78%)
Ex-Dividend Date	May 15, 2025

Volume	44,901
Average Volume	44,350
Open	2.750
Previous Close	2.750
Day's Range	2.730 - 2.840
52-Week Range	2.460 - 3.400
Beta	1.05
RSI	53.38
Earnings Date	Feb 27, 2026

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements und... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1929

Employees 1,437

Stock Exchange Madrid Stock Exchange

Ticker Symbol RJF

Full Company Profile

Financial Performance

In 2024, Laboratorio Reig Jofre's revenue was 341.37 million, an increase of 7.36% compared to the previous year's 317.95 million. Earnings were 10.38 million, an increase of 10.36%.

Financial Statements

News

There is no news available yet.